Markets:

Overview

News

Currencies

International

Treasuries

Biomea Fusion, Inc. - Common Stock (NQ:BMEA)

1.055 -0.035 (-3.21%)

Streaming Delayed Price Updated: 9:37 AM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biomea Fusion, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 01, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 01, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

BMEA Stock Earnings: Biomea Fusion Misses EPS for Q4 2023 ↗

April 01, 2024

BMEA stock results show that Biomea Fusion missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Recap: Biomea Fusion Q4 Earnings ↗

April 01, 2024

Via Benzinga

What's Going On With Biomea Fusion Stock? ↗

December 11, 2023

Biomea Fusion, Inc. (NASDAQ: BMEA) shares are trading lower Monday.

Via Benzinga

Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219

April 01, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

April 01, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode ↗

March 07, 2024

Bullish speculators could have their opportunity to blow up the bears with these short-squeeze stocks to buy.

Via InvestorPlace

Biomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219’s 28-Day Treatment Cycle, Supporting Improved Pancreatic Function

March 06, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

March 01, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Feeling Shut Out? 3 Sizzling Stocks and the Pull-Back Prices to Watch For ↗

February 19, 2024

Although FOMO can burn, investors will want to be careful with these stock prices to watch as a little patience can go a long way.

Via InvestorPlace

3 Speculative Stocks That Could Make Your February Unforgettable ↗

February 18, 2024

Gambling isn’t for everyone. However, if you’re dead set on speculative stocks, these ideas could shift the odds in your favor.

Via InvestorPlace

3 Long-Term Stocks to Buy on the Dip: February 2024 ↗

February 08, 2024

Although these ideas might not be the most exciting in the market, their predictability makes them excellent long-term stocks to buy.

Via InvestorPlace

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 25, 2024

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.

Via Benzinga

Alaska Air Posts Upbeat Earnings, Joins Xerox, United Rentals And Other Big Stocks Moving Higher On Thursday ↗

January 25, 2024

U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Shares of Alaska Air Group, Inc. (NYSE: ALK) rose during Thursday’s session following upbeat earnings.

Via Benzinga

Topics Stocks

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 10, 2024

Via Benzinga

Biomea Fusion Highlights Recent Updates and Anticipated 2024 Corporate Milestones at 42nd Annual J.P. Morgan Healthcare Conference

January 09, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Announces Dosing of First Type 1 Diabetes Patient in Phase II Study (COVALENT-112) with BMF-219

January 08, 2024

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes

From Biomea Fusion, Inc.

Via GlobeNewswire

Jim Cramer Says Move On From This Energy Stock: 'It's Moved Too Much' ↗

January 03, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended moving on from Tidewater Inc. (NYSE: TDW). "It’s moved too much," he added.

Via Benzinga

Biomea Fusion to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 11, 2023

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 11, 2023

Via Benzinga

Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday ↗

December 11, 2023

U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday. Here are some other big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Biomea Fusion Presents Achievement of Minimal Residual Disease Negativity (MRD-neg) in First Complete Responder from Ongoing Phase I Study (COVALENT-101) of BMF-219 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) at the 2023 ASH

December 11, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 11, 2023

Via Benzinga

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket ↗

December 11, 2023

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some...

Via Benzinga

Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts

December 09, 2023

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells with the aim to cure diabetes

From Biomea Fusion, Inc.

Via GlobeNewswire

Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 08, 2023

Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session following weak quarterly earnings.

Via Benzinga

Why Is Cancers/Metabolic Diseases-Focused Biomea Fusion Stock Trading Lower Today? ↗

December 08, 2023

Biomea Fusion Inc (NASDAQ: BMEA) announced the poster presentation of long-term 26 weeks follow-up data from the first two cohorts of adults with type 2 diabetes (T2D) enrolled in the ongoing Phase 2...

Via Benzinga

Biomea Fusion Presents Long-Term Follow-Up Data Showing Improved Glycemic Control after 22 Weeks Off Treatment in Ongoing Phase II Study (COVALENT-111) of BMF-219 in Adults with Type 2 Diabetes in a Poster Presentation at the World Congress Insulin

December 08, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.